Public Release: 

Untreated high blood pressure significantly increases risk of bleeding stroke

American Stroke Association Meeting Report -- Abstract 126 (Room 152) -- This news release contains updated information from the abstract

American Heart Association

LOS ANGELES, Feb. 18, 2016 - Left untreated, high blood pressure may significantly increase your risk of developing a brain bleed, according to research presented at the American Stroke Association's International Stroke Conference 2016.

Intracerebral hemorrhage is a type of stroke caused by a weakened blood vessel that ruptures and bleeds into brain tissue. High blood pressure is a powerful determinant of risk for intracerebral hemorrhage.

Researchers examined six-years of data from 4,646 patients who were white, black or Hispanic. Half of them had an intracerebral hemorrhage.

They found:

Compared to people without high blood pressure, untreated high blood pressure increased the odds of a brain bleed by 9.5 times in whites, 9.7 times in Hispanics, and 11.1 times in blacks.

For people with high blood pressure, untreated high blood pressure was linked to a 3.7 to 5.5 higher odds of brain bleed compared to when it's treated.

For patients with brain bleed and a previous diagnosis of high blood pressure, high blood pressure was more likely to not be treated in blacks (43.3 percent untreated) and Hispanics (48.3 percent) compared to whites (33.2 percent).

Even when high blood pressure was treated, blacks still had a 75 percent higher odds and Hispanics had a 50 percent higher odds of brain bleed, compared to whites.

"The average age for a brain hemorrhage is much younger in minorities, especially in African-Americans, so they may suffer more disability earlier in life than others," said Kyle Walsh, M.D., study author and an assistant professor of Emergency Medicine at the University of Cincinnati in Ohio.

Although it's not completely clear why racial minorities have higher rates of untreated high blood pressure, a possible reason is access to medical care, Walsh said.

The study analyzed data from the Ethnic/Racial Variations of ICH (ERICH) study, which followed people from 42 different sites. Each of the 2,323 people with bleeding stroke was matched with another person similar in age, gender, race/ethnicity, and geographic area, but who did not have a history of this type of stroke.

Researchers gathered blood pressure information based on participants' medical history. They analyzed the number of cases with high blood pressure, including treated vs. untreated high blood pressure, and the associated risk of bleeding stroke. The researchers also controlled for the effects of several factors including alcohol, cholesterol, education, insurance status, and blood thinning medications.

"It's important to be aware of having high blood pressure in the first place, and once diagnosed, to have it treated appropriately," Walsh said.


Co-authors are Daniel Woo, M.D., M.S.; Padmini Sekar, M.S.; Jennifer Osborne, R.N., B.S.N.; Charles Moomaw, Ph.D.; Carl Langefeld, Ph.D.; and Opeolu Adeoye, M.D., M.S. Author disclosures are on the abstract.

The ERICH study was funded by the National Institute of Neurological Disorders and Stroke.

Additional Resources:

Any available downloadable video/audio interviews, B-roll, animation, graphic, and images related to this news release are on the right column of the release link

Video clips with researchers/authors of the studies will be added to the release link as available.
High blood pressure risk calculator
Comprehensive stroke centers may improve bleeding stroke survival.
Costs to treat bleeding strokes increase 10 years later.
Hispanics and heart disease, stroke
Follow news from ASA International Stroke Conference 2016 via Twitter @HeartNews #ISC16.

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.